Niiki Pharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://niikipharma.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- Niiki Pharma Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT01415297
- Locations
- 🇺🇸
TGEN Clinical Research Services at Scottsdale Healthcare, Scottsdale, Arizona, United States
🇺🇸The Sarah Cannon Research Institute, Nashville, Tennessee, United States
News
No news found